CG
LGND icon

Clinton Group’s Ligand Pharmaceuticals LGND Stock Holding History

Clinton Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,708
Closed -$315K – 976
2016
Q1 		$315K Buy
+4,708
New +$315K 0.02% 729